SpringerLink
Log in

Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: analysis of human brain tissue

  • Original Paper
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Abstract

Mucopolysaccharidoses (MPS) are inherited disorders caused by the deficiency of lysosomal enzymes. Sanfilippo syndrome (MPS III) and Hunter syndrome (MPS II) are characterized by severe and mild neurological disorders, respectively, in which the neurodegenerative mechanisms remain to be clarified. We immunohistochemically examined the involvement of tauopathy/synucleinopathy, cell death and oxidative damage in the brains of three cases each of MPS IIIB and MPS II and age-matched controls. In cases of MPS IIIB, the density of GABAergic interneurons in the cerebral cortex immunoreactive for calbindin-D28K and parvalbumin was markedly reduced when compared with age-matched controls. The swollen neurons showed immunoreactivity for phosphorylated α-synuclein but not for phosphorylated tau protein or β-amyloid protein; those in the cerebral cortex demonstrated nuclear immunoreactivity for TUNEL, single-stranded DNA and 8-OHdG. Neither lipid peroxidation nor protein glycation was marked in MPS cases. The expression levels of superoxide dismutases (Cu/ZnSOD and MnSOD) and glial glutamate transporters (EAAT1 and EAAT2) were reduced in two MPS II cases. The disturbance of GABAergic interneurons can be related to mental disturbance, while synucleinopathy and/or DNA impairment may be implicated in the neurodegeneration of swelling neurons due to storage materials in MPS IIIB cases. These findings suggest the possibility of neuroprotective therapies other than enzyme replacement in MPS patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Arai M, Sasaki A, Saito N, Nakazato Y (2005) Immunohistochemical analysis of cleaved caspase-3 detects high level of apoptosis frequently in diffuse large B-cell lymphomas of the central nervous system. Pathol Int 55:122–129

    Article  PubMed  CAS  Google Scholar 

  2. Barone R, Nigro F, Triulzi F, Musumeci S, Fiumara A, Pavone L (1999) Clinical and neuroradiological follow-up in mucopolysaccharidosis type III (Sanfilippo syndrome). Neuropediatrics 30:270–274

    PubMed  CAS  Google Scholar 

  3. Beasley CL, Zhang ZJ, Patten I, Reynolds GP (2002) Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol Psychiatry 52:708–715

    Article  PubMed  CAS  Google Scholar 

  4. Ferrer I, Cusi V, Pineda M, Galofre E, Vila J (1988) Focal dendritic swellings in Purkinje cells in mucopolysaccharidoses types I, II and III. A Golgi and ultrastructural study. Neuropathol Appl Neurobiol 14:315–323

    PubMed  CAS  Google Scholar 

  5. Fridovich I (1995) Superoxide radical and superoxide dismutases. Annu Rev Biochem 64:97–112

    Article  PubMed  CAS  Google Scholar 

  6. Ginsberg SD, Galvin JE, Lee VM, Rorke LB, Dickson DW, Wolfe JH, Jones MZ, Trojanowski JQ (1999) Accumulation of intracellular amyloid-beta peptide (A beta 1–40) in mucopolysaccharidosis brains. J Neuropathol Exp Neurol 58:815–824

    Article  PubMed  CAS  Google Scholar 

  7. Hachiya Y, Hayashi M, Kumada S, Uchiyama A, Tsuchiya K, Kurata K (2006) Mechanisms of neurodegeneration in neuronal ceroid-lipofuscinosis. Acta Neuropathol 111:168–177

    Article  PubMed  CAS  Google Scholar 

  8. Hayashi M, Itoh M, Araki S, Kumada S, Shioda K, Tamagawa K, Mizutani T, Morimatsu Y, Minagawa M, Oda M (2001) Oxidative stress and disturbed glutamate transport in hereditary nucleotide repair disorders. J Neuropathol Exp Neurol 60:350–356

    PubMed  CAS  Google Scholar 

  9. Hayashi M, Arai N, Satoh J, Suzuki H, Katayama K, Tamagawa K, Morimatsu Y (2002) Neurodegenerative mechanisms in subacute sclelosing panencephalitis. J Child Neurol 17:725–730

    PubMed  Google Scholar 

  10. Hayashi M, Araki S, Kohyama J, Shioda K, Fukatsu R (2005) Oxidative nucleotide damage and superoxide dismutase expression in the brains of xeroderma pigmentosum group A and Cockayne syndrome. Brain Dev 27:34–38

    Article  PubMed  Google Scholar 

  11. Hayashi M, Kumada S, Shioda K, Fukatsu R (2007) Neuropathological analysis of the brainstem and cerebral cortex lesions on epileptogenesis in hereditary dentatorubral-pallidoluysian atrophy. Brain Dev 29:473–481

    Article  PubMed  Google Scholar 

  12. Kato H, Kogure K, Araki T, Liu XH, Kato K, Itoyama Y (1995) Immunohistochemical localization of superoxide dismutase in the hippocampus following ischemia in a gerbil model of ischemic tolerance. J Cereb Blood Flow Metab 15:60–70

    PubMed  CAS  Google Scholar 

  13. Kumada S, Hayashi M, Mizuguchi M, Nakano I, Morimatsu Y, Oda M (2000) Cerebellar degeneration in hereditary dentatorubral-pallidoluysian atrophy and Machado-Joseph disease. Acta Neuropathol 99:48–54

    Article  PubMed  CAS  Google Scholar 

  14. Kurihara M, Kumagai K, Goto K, Imai M, Yagishita S (1992) Severe type Hunter’s syndrome. Polysomnographic and neuropathological study. Neuropediatrics 23:248–256

    PubMed  CAS  Google Scholar 

  15. Matheus MG, Castillo M, Smith JK, Armao D, Towle D, Muenzer J (2004) Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation. Neuroradiology 46:666–672

    Article  PubMed  Google Scholar 

  16. McGlynn R, Dobrenis K, Walkley SU (2004) Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders. J Comp Neurol 480:415–426

    Article  PubMed  CAS  Google Scholar 

  17. Mikkonen M, Alafuzoff I, Tapiola T, Alafuzoff I, Miettinen R (1999) Subfield- and layer-specific changes in parvalbumin, calretinin and calbindin-D28K immunoreactivity in the entorhinal cortex in Alzheimer’s disease. Neuroscience 92:515–532

    Article  PubMed  CAS  Google Scholar 

  18. Muenzer J, Gucsavas-Calikoglu M, McCandless SE, Schuetz TJ, Kimura A (2007) A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome). Mol Genet Metab 90:329–337

    Article  PubMed  CAS  Google Scholar 

  19. Ohmi K, Greenberg DS, Rajavel KS, Ryazantsev S, Li HH, Neufeld EF (2003) Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc Natl Acad Sci USA 100:1902–1907

    Article  PubMed  CAS  Google Scholar 

  20. Revesz T, Ghiso J, Lashley T, Plant G, Rostagno A, Frangione B, Holton JL (2003) Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol 62:885–898

    PubMed  CAS  Google Scholar 

  21. Saito Y, Suzuki K, Hulette CM, Murayama S (2004) Aberrant phosphorylation of α-synuclein in human Niemann-Pick type C1 disease. J Neuropathol Exp Neurol 63:323–328

    PubMed  CAS  Google Scholar 

  22. Seto T, Kono K, Morimoto K, Inoue Y, Shintaku H, Hattori H, Matsuoka O, Yamano T, Tanaka A (2001) Brain magnetic resonance imaging in 23 patients with mucopolysaccharidoses and the effect of bone morrow transplantation. Ann Neurol 50:79–92

    Article  PubMed  CAS  Google Scholar 

  23. Suzuki K, Iseki E, Togo T, Yamaguchi A, Katsuse O, Katsuyama K, Kanzaki S, Shiozaki K, Kawanishi C, Yamashita S, Tanaka Y, Yamanaka S, Hirayasu Y (2007) Neuronal and glial accumulation of α- and β-synucleins in human lipidoses. Acta Neuropathol 114:481–489

    Article  PubMed  CAS  Google Scholar 

  24. Takahashi Y, Sukegawa K, Aoki M, Ito A, Suzuki K, Sakaguchi H, Watanabe M, Isogai K, Mizuno S, Hoshi H, Kuwata K, Tomatsu S, Kato S, Ito T, Kondo N, Orii T (2001) Evaluation of accumulated mucopolysaccharides in the brain of patients with mucopolysaccharidoses by 1H-magnetic resonance spectroscopy before and after bone marrow transplantation. Pediatr Res 49:349–355

    Article  PubMed  CAS  Google Scholar 

  25. Tamagawa K, Morimatsu Y, Fujisawa K, Hara A, Taketomi T (1985) Neuropathological study and chemico-pathological correlation in sibling cases of Sanfilippo syndrome type B. Brain Dev 7:599–609

    PubMed  CAS  Google Scholar 

  26. Villani GR, Gargiulo N, Faraonio R, Castaldo S, Gonzalez Y Reyero E, Di Natale P (2007) Cytokines, neurotrophins, and oxidative stress in brain disease from mucopolysaccharidosis IIIB. J Neurosci Res 85:612–622

    Article  PubMed  CAS  Google Scholar 

  27. Walkley SU, Thrall MA, Haskins ME, Mitchell TW, Wenger DA, Brown DE, Dial S, Seim H (2005) Abnormal neuronal metabolism and storage in mucopolysaccharidosis type VI (Maroteaux-Lamy) disease. Neuropathol Appl Neurobiol 31:536–544

    Article  PubMed  CAS  Google Scholar 

  28. Wraith JE, Clarke LA, Beck M, Kolodne EH, Pastores GM, Muenzer J, Rapoport DM, Berger KI, Swiedler SJ, Kakkis ED, Braakman T, Chadbourne E, Walton-Bowen K, Cox GF (2004) Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-l-iduronidase (laronidase). J Pediatr 144:581–588

    Article  PubMed  CAS  Google Scholar 

  29. Zafeiriou DI, Savvopoulou-Augoustidou PA, Sewell A, Papadopoulou F, Badouraki M, Vargiami E, Gombakis NP, Katzos GS (2001) Serial magnetic resonance imaging findings in mucopolysaccharidosis IIIB (Sanfilippo’s syndrome B). Brain Dev 23:385–389

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Neuropathology, Tokyo Metropolitan Institute for Neuroscience, Tokyo, Japan

    Kimiko Hamano & Masaharu Hayashi

  2. Department of Pediatrics, Tokyo Medical and Dental University, Tokyo, Japan

    Kimiko Hamano & Shuki Mizutani

  3. Department of Neuropathology, Saitama Medical College, Iruma, Saitama, Japan

    Kei Shioda & Ryo Fukatsu

  4. Department of Pediatrics, Sassa General Hospital, 4-24-15 Tanashi-cho, Nishitokyo-shi, Tokyo, 188-0011, Japan

    Kimiko Hamano

Authors
  1. Kimiko Hamano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masaharu Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kei Shioda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ryo Fukatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shuki Mizutani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kimiko Hamano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hamano, K., Hayashi, M., Shioda, K. et al. Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: analysis of human brain tissue. Acta Neuropathol 115, 547–559 (2008). https://doi.org/10.1007/s00401-007-0325-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-007-0325-3

Keywords

Search

Navigation